4-bromo-N-(2-methylbut-3-yn-2-yl)benzamide(80045-50-7)
- Name: 4-bromo-N-(2-methylbut-3-yn-2-yl)benzamide
- Synonyms:N-(1,1-dimethyl-2-propyn-1-yl)-4-bromobenzamide;BROMOPROPYZAMIDE;
- Molecular Formula:C12H12BrNO
- Molecular Weight:266.13
- CAS Registry Number:80045-50-7
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.80045-50-7 4-bromo-N-(2-methylbut-3-yn-2-yl)benzamide
Assay:99% Appearance:powder or liquid Package:according to customer requirements Storage:store in dry dark and ventilated place Transportation:By Sea/Air/Courier Application:It is an important raw material.
Min. Order:10Gram
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.80045-50-7 4-bromo-N-(2-methylbut-3-yn-2-yl)benzamide
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.80045-50-7 4-bromo-N-(2-methylbut-3-yn-2-yl)benzamide
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:4-bromo-N-(2-methylbut-3-yn-2-yl)benzamide
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]
Other Product
- 110933-26-1/(2,3,3-trimethyloxiran-2-yl)methanol
- 20031-27-0/acetic acid, isocyano-, methyl ester
- 10155-47-2/3-HYDROXY-N-[3-(4-MORPHOLINYL)PROPYL]-2-NAPHTHALENECARBOXAMIDE
- 68214-55-1/sodium 3-[[4-[(4-ethoxy-m-tolyl)azo]-1-naphthyl]azo]benzenesulphonate
- 57212-36-9/2-FLUOROHISTIDINE
- 552-63-6/DL-TROPIC ACID
- 19578-92-8/1-(3,4-Dimethoxyphenyl)-2-propanol
- 505-19-1/Hexahydropyridazin
- 372-63-4/(E)-bis(trifluoromethyl)diazene
- 137-18-8/P-XYLOQUINONE
- 19104-24-6/8-HYDROXY-1-METHYLQUINOLINIUM METHYL SULFATE
- 84968-79-6/[2-(6-chloro-1,3-benzothiazol-2-yl)-5-methyl-3-oxo-2,3-dihydro-1H-pyrazol-4-yl]acetic acid
- 90268-23-8/Pigment Yellow 126
- 64660-82-8/Pyrimidine, 4-(phenylmethyl)- (9CI)
- 25865-94-5/2-hydroxy-3-[1-(5-hydroxy-2,6,6-trimethyltetrahydro-2H-pyran-2-yl)ethyl]quinolin-4(1H)-one
- 124041-05-0/ethyl {[6-(4-methylphenoxy)pyrimidin-4-yl]sulfanyl}acetate
- 147025-54-5/talsaclidine fumarate
- 80045-50-7/4-bromo-N-(2-methylbut-3-yn-2-yl)benzamide
- 94-84-8/2,4-DEP emulsion(content>35%)
- 165967-62-4/6H-Indolo[3,2,1-de][1,5]naphthyridin-6-one,10-hydroxy-1,11-dimethoxy-
- 9033-12-9/EC 4.4.1.5
- 22112-79-4/5,10,15,20-tetra(3-hydroxyphenyl)porphyrin
- 57833-28-0/sodium 4-ethenylbenzenesulfonate - 2-methylprop-2-enoic acid (1:1)
- 483-87-4/1,7-Dimethylphenanthrene
- 1002-53-5/di-n-butyltin
- 119557-99-2/ALPHA-HOMONOJIRIMYCIN
- 124431-80-7/CGS 21680A
- 12636-57-6/Ferricenium trichloroacetate
- 79992-73-7/sodium; (2R,3R,4S,5R,6R)-2-[(2R,3S,4R,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol; 7-hydroxy-10-oxido-phenoxazin-3-one; azide
- 15610-97-6/Methyl 16α-(benzoyloxy)-20-hydroxy-14α-methoxyhimbosan-18-oate